Table 4.
Comparison of individualised prognostics predictions of 10 and 15 year overall survival and treatment benefit outcomes (radical treatment versus conservative management) based on the Predict Prostate algorithm (https://prostate.predict.nhs.uk) using either clinical based characterisation (DRE + systematic sampling only) versus MRI based characterisation (MRI staging and combined MRI targeted and systematic sampling)
| 10-year survival outcome | No change in predicted outcome | 288 (81.3%) |
| (n = 354) | ||
| Number with a change | 66 (18.7%) | |
| Range of change in survival | -20% to 9% | |
| Mean change in survival | -1.86% | |
| Median change in survival | -1.0% | |
| 10-year treatment benefit | No change in estimated benefit | 302 (85.4%) |
| Number with a change | 52 (14.6%) | |
| Range of change in benefit | -4 to 8% | |
| Mean change in benefit | -1.05% | |
| Median change in benefit | -1.0% | |
| 15-year survival outcome | No change in predicted outcome | 279 (78.8%) |
| (n = 354) | ||
| Number with a change | 75 (21.2%) | |
| Range of change in survival | -27% to 9% | |
| Mean change in survival | -2.4% | |
| Median change in survival | -2% | |
| 15-year treatment benefit | No change in estimated benefit | 288 (81.3%) |
| Number with a change | 66 (18.7%) | |
| Range of change in benefit | -4 to 10% | |
| Mean change in benefit | 1.1% | |
| Median change in benefit | 1.0% | |